temozolomide has been researched along with Peritoneal Neoplasms in 2 studies
Peritoneal Neoplasms: Tumors or cancer of the PERITONEUM.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 2 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Schwartz, S | 1 |
| Szeto, C | 1 |
| Tian, Y | 1 |
| Cecchi, F | 1 |
| Corallo, S | 1 |
| Calegari, MA | 1 |
| Di Bartolomeo, M | 1 |
| Morano, F | 1 |
| Raimondi, A | 1 |
| Fucà, G | 1 |
| Martinetti, A | 1 |
| De Pascalis, I | 1 |
| Martini, M | 1 |
| Belfiore, A | 1 |
| Milione, M | 1 |
| Orlandi, A | 1 |
| Barault, L | 1 |
| Barone, C | 1 |
| de Braud, F | 1 |
| Di Nicolantonio, F | 1 |
| Benz, S | 1 |
| Hembrough, T | 1 |
| Pietrantonio, F | 1 |
| Pinnix, CC | 1 |
| Fontanilla, HP | 1 |
| Hayes-Jordan, A | 1 |
| Subbiah, V | 1 |
| Bilton, SD | 1 |
| Chang, EL | 1 |
| Grosshans, DR | 1 |
| McAleer, MF | 1 |
| Sulman, EP | 1 |
| Woo, SY | 1 |
| Anderson, P | 1 |
| Green, HL | 1 |
| Mahajan, A | 1 |
| Trial | Phase | Enrollment | Study Type | Start Date | Status | ||
|---|---|---|---|---|---|---|---|
| Multicenter Phase II Study of Preoperative Chemoradiotherapy With CApecitabine Plus Temozolomide in Patients With MGMT Silenced and Microsatellite Stable Locally Advanced RecTal Cancer: the CATARTIC Trial[NCT05136326] | Phase 2 | 21 participants (Anticipated) | Interventional | 2021-12-01 | Recruiting | ||
| Temozolomide and Irinotecan Consolidation in Patients With MGMT Silenced, Microsatellite Stable Colorectal Cancer With Persistence of Minimal Residual Disease in Liquid Biopsy After Standard Adjuvant Chemotherapy: the ERASE-TMZ Study[NCT05031975] | Phase 2 | 35 participants (Anticipated) | Interventional | 2022-05-02 | Recruiting | ||
| [information is prepared from clinicaltrials.gov, extracted Sep-2024] | |||||||
1 trial available for temozolomide and Peritoneal Neoplasms
| Article | Year |
|---|---|
Refining the selection of patients with metastatic colorectal cancer for treatment with temozolomide using proteomic analysis of O6-methylguanine-DNA-methyltransferase.
Topics: Aged; Aged, 80 and over; Antineoplastic Agents, Alkylating; Biomarkers, Tumor; Colorectal Neoplasms; | 2019 |
Refining the selection of patients with metastatic colorectal cancer for treatment with temozolomide using proteomic analysis of O6-methylguanine-DNA-methyltransferase.
Topics: Aged; Aged, 80 and over; Antineoplastic Agents, Alkylating; Biomarkers, Tumor; Colorectal Neoplasms; | 2019 |
Refining the selection of patients with metastatic colorectal cancer for treatment with temozolomide using proteomic analysis of O6-methylguanine-DNA-methyltransferase.
Topics: Aged; Aged, 80 and over; Antineoplastic Agents, Alkylating; Biomarkers, Tumor; Colorectal Neoplasms; | 2019 |
Refining the selection of patients with metastatic colorectal cancer for treatment with temozolomide using proteomic analysis of O6-methylguanine-DNA-methyltransferase.
Topics: Aged; Aged, 80 and over; Antineoplastic Agents, Alkylating; Biomarkers, Tumor; Colorectal Neoplasms; | 2019 |
1 other study available for temozolomide and Peritoneal Neoplasms
| Article | Year |
|---|---|
Whole abdominopelvic intensity-modulated radiation therapy for desmoplastic small round cell tumor after surgery.
Topics: Abdominal Neoplasms; Adolescent; Antibodies, Monoclonal, Humanized; Antineoplastic Agents; Antineopl | 2012 |